These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 36838752)

  • 21. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.
    Wang H; Chen D; Lu H
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3957-3972. PubMed ID: 35648146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Old and new targets of antibacterial therapy.
    Dbaibo GS
    J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use.
    Neu HC
    Am J Med; 1986 Jun; 80(6B):195-203. PubMed ID: 3460336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
    Martelli G; Giacomini D
    Eur J Med Chem; 2018 Oct; 158():91-105. PubMed ID: 30205261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of aminoglycoside antibiotics by carbohydrate chemistry.
    Guo L; Wan Y; Wang X; Wang PG; Zhao W
    Mini Rev Med Chem; 2012 Dec; 12(14):1533-41. PubMed ID: 22827181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
    Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
    Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.
    Uddin TM; Chakraborty AJ; Khusro A; Zidan BRM; Mitra S; Emran TB; Dhama K; Ripon MKH; Gajdács M; Sahibzada MUK; Hossain MJ; Koirala N
    J Infect Public Health; 2021 Dec; 14(12):1750-1766. PubMed ID: 34756812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial resistance: an overview.
    Kushwah A; Gandhe M; Patel P
    J Indian Med Assoc; 2013 Apr; 111(4):260-3. PubMed ID: 24475559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial Agents.
    Hobson C; Chan AN; Wright GD
    Chem Rev; 2021 Mar; 121(6):3464-3494. PubMed ID: 33606500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens.
    Deng C; Yan H; Wang J; Liu K; Liu BS; Shi YM
    Eur J Med Chem; 2022 Dec; 244():114888. PubMed ID: 36334453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid antibiotics - clinical progress and novel designs.
    Parkes AL; Yule IA
    Expert Opin Drug Discov; 2016 Jul; 11(7):665-80. PubMed ID: 27169483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging nanozyme-based multimodal synergistic therapies in combating bacterial infections.
    Zhang Y; Hu X; Shang J; Shao W; Jin L; Quan C; Li J
    Theranostics; 2022; 12(13):5995-6020. PubMed ID: 35966582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial properties and clinical potential of pleuromutilins.
    Goethe O; Heuer A; Ma X; Wang Z; Herzon SB
    Nat Prod Rep; 2019 Jan; 36(1):220-247. PubMed ID: 29979463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.